Amendment 256, after recital 12
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – After recital 12 – Am 256
Adopted
- For
- 362
- Against
- 259
- Abstained
- 34
roll-call vote at 12:50 · 55% of votes cast in favour
Roll call requested by Renew
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 39 | 0 | 0 | 39 | For |
| Greens | 51 | 0 | 0 | 51 | For |
| S&D | 123 | 1 | 2 | 126 | For |
| Renew | 62 | 1 | 5 | 68 | For |
| EPP | 35 | 129 | 9 | 173 | Against |
| ECR | 2 | 65 | 4 | 71 | Against |
| Patriots | 35 | 34 | 8 | 77 | Divided |
| ESN | 0 | 23 | 1 | 24 | Against |
| No group | 15 | 6 | 5 | 26 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
39 MEPs of 655 Clear filters
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.